Consumer products behemoth Proctor & Gamble (NYSE: PG) will be reporting earnings this Thursday before market open. Here’s what you need to know.

Procter & Gamble beat analysts’ revenue expectations by 1% last quarter, reporting revenues of $22.39 billion, up 3% year on year. It was a strong quarter for the company, with an impressive beat of analysts’ EBITDA estimates and a narrow beat of analysts’ revenue estimates.

Is Procter & Gamble a buy or sell going into earnings? Read our full analysis here, it’s free for active Edge members.

This quarter, analysts are expecting Procter & Gamble’s revenue to grow 1.9% year on year to $22.29 billion, in line with the 2.1% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $1.86 per share.

Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Procter & Gamble has missed Wall Street’s revenue estimates five times over the last two years.

Looking at Procter & Gamble’s peers in the consumer staples segment, some have already reported their Q4 results, giving us a hint as to what we can expect. WD-40 posted flat year-on-year revenue, meeting analysts’ expectations, and Constellation Brands reported a revenue decline of 9.8%, topping estimates by 2.9%. WD-40 traded down 6.6% following the results while Constellation Brands was up 5.3%.

Read our full analysis of WD-40’s results here and Constellation Brands’s results here.

There has been positive sentiment among investors in the consumer staples segment, with share prices up 3.6% on average over the last month. Procter & Gamble is up 2.7% during the same time and is heading into earnings with an average analyst price target of $165.32 (compared to the current share price of $146.50).

When a company has more cash than it knows what to do with, buying back its own shares can make a lot of sense–as long as the price is right. Luckily, we’ve found one, a low-priced stock that is gushing free cash flow AND buying back shares. Click here to claim your Special Free Report on a fallen angel growth story that is already recovering from a setback.